Charles Lefebvre
Impact in
- Immunology top 5%
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
Papers in
-
- Cell death mechanisms and regulation 8
- RNA Interference and Gene Delivery 6
- CRISPR and Genetic Engineering 4
- RNA and protein synthesis mechanisms 4
- Genetics 12
- Virus-based gene therapy research 12
- Neurogenetic and Muscular Disorders Research 3
- Co-authors
- Robert G. Korneluk (11 shared papers)Martin Holčı́k (5 shared papers)Alex MacKenzie (4 shared papers)Stephen Baird (6 shared papers)Reza Mastery Farahani (2 shared papers)Michael D. McLean (2 shared papers)Natalie Roy (2 shared papers)Katsuyuki Tamai (1 shared paper)
- Journals
- Genomics (5 papers)Molecular Therapy (2 papers)Molecular Therapy — Oncolytics (2 papers)Journal of Visualized Experiments (2 papers)Cancer Immunology Research (2 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Charles Lefebvre
28 papers receiving 2.2k citations
Charles Lefebvre's Hit Papers
Peers
Comparison fields: 5 of 108
- Immunology 564
- Molecular Biology 1.7k
- Cancer Research 293
- Oncology 528
- Genetics 157
Countries citing papers authored by Charles Lefebvre
This map shows the geographic impact of Charles Lefebvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lefebvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lefebvre more than expected).
Fields of papers citing papers by Charles Lefebvre
This network shows the impact of papers produced by Charles Lefebvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lefebvre. The network helps show where Charles Lefebvre may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Lefebvre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes Hit paper breakdown → | 1996 | 859 |
| 2 | 1999 | 266 | |
| 3 | 2005 | 162 | |
| 4 | 2004 | 141 | |
| 5 | 2010 | 115 | |
| 6 | 2000 | 79 | |
| 7 | 2011 | 77 | |
| 8 | 2005 | 64 | |
| 9 | 2017 | 59 | |
| 10 | 2005 | 57 | |
| 11 | 2014 | 54 | |
| 12 | 1998 | 50 | |
| 13 | 1996 | 42 | |
| 14 | 1999 | 36 | |
| 15 | 2002 | 35 | |
| 16 | 2017 | 32 | |
| 17 | 1995 | 31 | |
| 18 | 2018 | 28 | |
| 19 | 2018 | 23 | |
| 20 | 1996 | 18 |
About Charles Lefebvre
Charles Lefebvre is a scholar working on Molecular Biology, Genetics, Immunology, Genetics and Ecology, Evolution, Behavior and Systematics, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Cell death mechanisms and regulation (8 papers), RNA Interference and Gene Delivery (6 papers), CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (4 papers), CAR-T cell therapy research (3 papers), Vector-Borne Animal Diseases (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). The work is most often cited by research in Immunology (564 citations), Molecular Biology (1.7k citations), Cancer Research (293 citations), Oncology (528 citations) and Genetics (157 citations). Charles Lefebvre has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Robert G. Korneluk, Martin Holčı́k, Alex MacKenzie, Stephen Baird, Reza Mastery Farahani, Michael D. McLean, Natalie Roy, Katsuyuki Tamai, Eric C. LaCasse and Terry Chow. Their work appears in journals such as Genomics, Molecular Therapy, Molecular Therapy — Oncolytics, Journal of Visualized Experiments and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.